(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202412 | 202312 | % Var | 202412 | 202312 | % Var | 202403 | 202303 | % Var | |
| Sales | 14.66 | 17.14 | -14.47 | 50.76 | 53.99 | -5.98 | 70.30 | 71.55 | -1.75 |
| Other Income | 0.77 | 0.48 | 60.42 | 2.22 | 1.68 | 32.14 | 2.75 | 1.72 | 59.88 |
| PBIDT | 1.41 | 1.88 | -25.00 | 6.19 | 5.85 | 5.81 | 8.17 | 7.81 | 4.61 |
| Interest | 0.05 | 0.10 | -50.00 | 0.26 | 0.27 | -3.70 | 0.37 | 0.52 | -28.85 |
| PBDT | 1.36 | 1.78 | -23.60 | 5.93 | 5.58 | 6.27 | 7.80 | 7.29 | 7.00 |
| Depreciation | 0.32 | 0.33 | -3.03 | 0.96 | 0.99 | -3.03 | 1.30 | 1.29 | 0.78 |
| PBT | 1.04 | 1.45 | -28.28 | 4.97 | 4.59 | 8.28 | 6.50 | 6.00 | 8.33 |
| TAX | 0.50 | 0.40 | 25.00 | 1.50 | 1.10 | 36.36 | 1.64 | 1.42 | 15.49 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.12 | -0.16 | -25.00 |
| PAT | 0.54 | 1.05 | -48.57 | 3.47 | 3.49 | -0.57 | 4.86 | 4.58 | 6.11 |
| Equity | 25.19 | 25.19 | 0.00 | 25.19 | 25.19 | 0.00 | 25.19 | 25.19 | 0.00 |
| PBIDTM(%) | 9.62 | 10.97 | -12.31 | 12.19 | 10.84 | 12.55 | 11.62 | 10.92 | 6.47 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: